BNP Paribas Asset Management’s Pediatrix Medical MD Stock Holding History

BNP Paribas Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.89M	Sell	114,240 -5,428	-5%	-$123K	﹤0.01%	1038
2026 Q1	$2.56M	Buy	119,668 +493	+0.4%	+$10.3K	﹤0.01%	1023
2025 Q4	$2.55M	Buy	119,175 +118,171	+11,770%	+$2.42M	﹤0.01%	1020
2025 Q3	$17K	Hold	1,004	–	–	﹤0.01%	1458
2025 Q2	$14K	Buy	+1,004	New	+$13.8K	﹤0.01%	1645
2017 Q3	–	Sell	-4,045	Closed	-$244K	–	948
2017 Q2	$244K	Sell	4,045 -90,989	-96%	-$5.39M	﹤0.01%	914
2017 Q1	$6.59M	Sell	95,034 -17,447	-16%	-$1.21M	0.06%	422
2016 Q4	$7.5M	Sell	112,481 -7,840	-7%	-$510K	0.07%	371
2016 Q3	$7.97M	Sell	120,321 -20,910	-15%	-$1.43M	0.07%	387
2016 Q2	$10.2M	Buy	141,231 +133,637	+1,760%	+$9.19M	0.09%	317
2016 Q1	$491K	Buy	7,594 +1,889	+33%	+$125K	﹤0.01%	957
2015 Q4	$409K	Buy	+5,705	New	+$422K	﹤0.01%	972

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

BNP Paribas Asset Management's MD Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Pediatrix Medical (MD) stake by 4.5% in Q2 2026, selling an estimated $123K and leaving 114,240 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

BNP Paribas Asset Management first reported a position in MD in Q4 2015 and has held it in 12 quarters since. The position peaked at $10.2M in Q2 2016. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

BNP Paribas Asset Management held 114,240 shares of Pediatrix Medical worth $2.89M as of Q2 2026.
BNP Paribas Asset Management sold 5,428 Pediatrix Medical shares in Q2 2026, an estimated $123K.
Pediatrix Medical made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1038 holding.
BNP Paribas Asset Management first reported a position in Pediatrix Medical in Q4 2015 and has held it in 12 quarters since.
BNP Paribas Asset Management's Pediatrix Medical position peaked at $10.2M in Q2 2016.
304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.